Just Patent Law Blog

Key points  Claim 1 is directed to the crystalline malate salt of the known pharmaceutical compound cabozantinib. As to novelty: “D29 [...

Key points The Board gives first a useful summary of the relationship between the principle of party disposition, the extent of appeal, and ...

Key points This decision provides yet a further contribution to the debate between the Boards about the question of whether cancelling indep...

Key points  This decision touches on a rather subtle point of waiver though more precisely, perhaps, forfeiture of objections (in the sense ...

Key points The patentee complains that the Board did not admit an auxiliary request under Art. 13(2) RPBA. The Board, on the relation betwee...

Key points  The AC decided, under the former President, that Rule 28(2) was to apply also retroactively to applications already pending on 0...

  Key points  Patents direct to salt forms, solvate forms, and polymorphs are commercially rather important in the pharma field. T 777/08 he...